^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CLN-049

    i
    Other names: CLN-049
    Associations
    News
    Trials
    Company:
    Cullinan Therap, German Cancer Research Center, University of Tuebingen
    Drug class:
    FLT3 inhibitor, CD3 agonist
    Related drugs:
    Associations
    News
    Trials